packageAbarelix

abarelix

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abarelix is a hormone antagonist that was used as endocrine therapy for cancer, mainly advanced prostate cancer. It has been withdrawn from the market and is no longer in clinical use.

Summary written by glm-5.3-flash from Wikidata Q305555 and the WHO ATC classification; not checked by a person.

name:abarelix
ATC codes:L02BX01
DrugBank:DB00106
PubChem CID:16131215
ChEBI:337298
Wikidata:Q305555
formula:C72H95ClN14O14
molar mass:1416.09 g/mol (PubChem CID 16131215)
logP:3.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown